JP2013506003A5 - - Google Patents

Download PDF

Info

Publication number
JP2013506003A5
JP2013506003A5 JP2012532230A JP2012532230A JP2013506003A5 JP 2013506003 A5 JP2013506003 A5 JP 2013506003A5 JP 2012532230 A JP2012532230 A JP 2012532230A JP 2012532230 A JP2012532230 A JP 2012532230A JP 2013506003 A5 JP2013506003 A5 JP 2013506003A5
Authority
JP
Japan
Prior art keywords
alkyl
group
isopropyl
methoxy
pyrazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012532230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013506003A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/050486 external-priority patent/WO2011041287A1/en
Publication of JP2013506003A publication Critical patent/JP2013506003A/ja
Publication of JP2013506003A5 publication Critical patent/JP2013506003A5/ja
Pending legal-status Critical Current

Links

JP2012532230A 2009-09-29 2010-09-28 スフィンゴシン−1−リン酸−2(s1p2)受容体のサブタイプ選択的調節因子としての縮合環ピリジン化合物 Pending JP2013506003A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24664209P 2009-09-29 2009-09-29
US61/246,642 2009-09-29
PCT/US2010/050486 WO2011041287A1 (en) 2009-09-29 2010-09-28 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors

Publications (2)

Publication Number Publication Date
JP2013506003A JP2013506003A (ja) 2013-02-21
JP2013506003A5 true JP2013506003A5 (enExample) 2013-11-14

Family

ID=43031503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012532230A Pending JP2013506003A (ja) 2009-09-29 2010-09-28 スフィンゴシン−1−リン酸−2(s1p2)受容体のサブタイプ選択的調節因子としての縮合環ピリジン化合物

Country Status (15)

Country Link
US (2) US8507682B2 (enExample)
EP (1) EP2483245A1 (enExample)
JP (1) JP2013506003A (enExample)
KR (1) KR20120087932A (enExample)
CN (1) CN102741232A (enExample)
AU (1) AU2010300791A1 (enExample)
BR (1) BR112012007095A2 (enExample)
CA (1) CA2775587A1 (enExample)
IL (1) IL218843A0 (enExample)
MX (1) MX2012003718A (enExample)
NZ (1) NZ599595A (enExample)
RU (1) RU2012114718A (enExample)
SG (1) SG10201406178WA (enExample)
WO (1) WO2011041287A1 (enExample)
ZA (1) ZA201202366B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013148460A1 (en) 2012-03-26 2013-10-03 Swenson Rolf E Novel sphingosine 1-phosphate receptor antagonists
WO2014158302A1 (en) * 2013-03-25 2014-10-02 Swenson Rolf Eric Novel sphingosine 1-phosphate receptor antagonists
CA2953208C (en) * 2014-06-02 2022-05-10 Dalhousie University Treatment of familial exudative vitreoretinopathy through s1pr2 inhibition
US10487082B2 (en) 2015-06-01 2019-11-26 Dalhousie University S1PR2 antagonists and uses therefor
US10858358B2 (en) 2015-06-01 2020-12-08 Dalhousie University S1PR2 antagonists and uses therefor
CN107849038A (zh) * 2015-06-01 2018-03-27 达尔豪西大学 S1pr2拮抗剂及其用途
CN107382965A (zh) * 2017-08-14 2017-11-24 河南科技大学第附属医院 具有抗肿瘤活性的新型s1p‑1受体激动剂药物分子的合成方法
CN113896646B (zh) * 2020-07-06 2023-06-02 浙江海森药业股份有限公司 一种4-甲基-3-氧代-n-苯基戊酰胺的高效绿色制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146810A3 (de) 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
US5110987A (en) 1988-06-17 1992-05-05 Emory University Method of preparing sphingosine derivatives
ZA902794B (en) 1989-04-18 1991-04-24 Duphar Int Res New 3-n substituted carbamoyl-indole derivatives
US5294722A (en) 1992-04-16 1994-03-15 E. R. Squibb & Sons, Inc. Process for the preparation of imidazoles useful in angiotensin II antagonism
US5403851A (en) 1994-04-05 1995-04-04 Interneuron Pharmaceuticals, Inc. Substituted tryptamines, phenalkylamines and related compounds
JP4001929B2 (ja) 1997-03-12 2007-10-31 タカラバイオ株式会社 スフィンゴシン類縁化合物
AU9002298A (en) 1997-09-11 1999-03-29 Takara Shuzo Co., Ltd. Sphingosine derivatives and medicinal composition
WO2001098301A1 (en) * 2000-06-20 2001-12-27 Japan Tobacco Inc. Pyrazolopyridine compounds and use thereof as drugs
US20020183762A1 (en) 2001-06-01 2002-12-05 Ams Research Corporation Bone anchor inserters and methods
WO2003000253A1 (en) 2001-06-20 2003-01-03 Wyeth Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
JPWO2003020313A1 (ja) * 2001-09-04 2004-12-16 小野薬品工業株式会社 スフィンゴシン−1−リン酸受容体調節剤からなる呼吸器疾患治療剤
WO2003051876A1 (en) * 2001-12-14 2003-06-26 Japan Tobacco Inc. Pyrazolopyridine derivatives and medicinal use thereof
GB0206876D0 (en) * 2002-03-22 2002-05-01 Merck Sharp & Dohme Therapeutic agents
US7429609B2 (en) 2002-05-31 2008-09-30 Eisai R & D Management Co., Ltd. Pyrazole compound and medicinal composition containing the same
WO2008154470A1 (en) 2007-06-08 2008-12-18 University Of Connecticut Nhibitor of the receptor activity of the s1p2 receptor for inhibiting pathological angiogenesis in the eye
WO2009074969A2 (en) * 2007-12-12 2009-06-18 University Of Lausanne Sphingosine-1-phosphate, analogs and antagonists for use as medicaments

Similar Documents

Publication Publication Date Title
JP2013506003A5 (enExample)
JP2013510122A5 (enExample)
RU2015126015A (ru) Новые улавливатели в лечении макулодистрофии
JP2013508279A5 (enExample)
RU2014113679A (ru) N-(2-амино-6,6-дифтор-4,4а,5,6,7,7а-гексагидро-циклопента[e][1,3]оксазин-4-ил)-фенил)-амиды в качестве ингибиторов бета-секретазы 1
JP2016505637A5 (enExample)
RU2012114718A (ru) Пиридиновые соединения конденсированного кольца как подтип-селективные модуляторы рецепторов сфингозин-1-фосфата-2 (s1p2)
JP2013543896A5 (enExample)
JP2004517087A5 (enExample)
JP2013519684A5 (enExample)
JP2013537203A5 (enExample)
JP2007505877A5 (enExample)
JP2014502979A5 (enExample)
JP2014505107A5 (enExample)
JP2012255002A5 (enExample)
JP2017517538A5 (enExample)
JP2016520618A5 (enExample)
RU2012103487A (ru) Ингибирующие jak соединения на основе пиразолопиримидина и способы
JP2013533253A5 (enExample)
JP2013531008A5 (enExample)
JP2008523126A5 (enExample)
RU2010101302A (ru) Замещенные оксазолидиноны и их применение
JP2010510237A5 (enExample)
JP2010522710A5 (enExample)
JP2015508092A5 (enExample)